Hepatic metastasis at diagnosis in patients with wilms tumor is not an independent adverse prognostic factor for stage IV wilms tumor: A report from the children's oncology group/national wilms tumor study group

Annals of Surgery

Volumn 250, Issue 4, 2009, Pages 642-647

  Ehrlich, Peter F ^a   Ferrer, Fernando A ^b   Ritchey, Michael L ^c   Anderson, James R ^d   Green, Daniel M ^e   Grundy, Paul E ^f   Dome, Jeffrey S ^g   Kalapurakal, John A ^h   Perlman, Elizabeth J ^h   Shamberger, Robert C ⁱ  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Division of Pediatric Infectious Diseases   (United States)

^c PHOENIX CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOTHERAPY; ADVERSE OUTCOME; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; HUMAN; INFANT; LIVER INJURY; LIVER LOBECTOMY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATECTOMY; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME; WILMS TUMOR;

EID: 70349658762     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b76f20     Document Type: Article

References (29)

1. Dome JS, Perlman EJ, Ritchey ML. Renal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lip-pincott Williams and Wilkins; 2006:905-932.
2. Green DM, Breslow N, Evans I, et al. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. Med Pediatr Oncol. 1996;26:147-152. (Pubitemid 26046143)
3. Green DM, Thomas PRM, Schocat S. The treatment of Wilms tumor. Results of the National Wilms Tumor Studies. Hematol Oncol Clin North Am. 1995;9:1267-1274.
4. Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxoru-bicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008;50:236-241.
5. Thomas PRM, Schocat S, Norkool P. Prognostic implications of hepatic adhesion, invasion, and metastases at diagnosis of Wilms? tumor. The National Wilms? Tumor Study Group. Cancer. 1991;68:2486-2488.
6. Varan A, Büyükpamukcu, Caglar M. Prognostic significance of metastatic site at diagnosis in Wilms? tumor: results from a single center. J Pediatr Hematol Oncol. 2005;27:188-191.
7. Szavay P, Luithle T, Graf N. Primary hepatic metastases in nephroblastoma-a report of the SIOP/GPOH Study. J Pediatr Surg. 2006;41:168-172.
8. Fuchs J, Szavay P, Luithle T, et al. Surgical implications for liver metastasis in nephroblastoma- data from the SIOP/GPOH study. Surg Oncol. 2008;17: 33-40.
9. Green DM. National Wilms Tumor Study Group 5 (NWTS-5) protocol. 1994. www.childrensoncologygroup.org/prot/default.asp.
10. Dome JS, Cotton CA, Perlman EJ. Treatment of anaplastic histology Wilms? tumor: results from the fifth National Wilms? Tumor Study. J Clin Oncol. 2006;24:2352-2358.
11. Grundy PE, Breslow N, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005;23:7312-7321.
12. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;33:457-481.
13. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc (A). 1972;135:185-206.
14. Fischer RA. On the interpretation of chi-squared from contingency tables, and the calculation of P. J Royal Stat Soc. 1922;855:87-94.
15. Grosfeld JL. Risk-based management: current concepts of treating malignant solid tumors of childhood. J Am Coll Surg. 1999;189:407-435.
16. Dome JS, Grundy PE, Perlman EJ, et al. Protocols for the Renal tumors Study, Childrens Oncology Group. Available at: www.childrensoncologygroup.org. Accessed 2007.
17. Ehrlich PF. Wilms tumor: progress to date and future considerations. Expert Rev Anticancer Ther. 2001;1:555-564.
18. Breslow N, Churchill G, Nessmith B, et al. Clinicopathologic features and prognosis for Wilms? tumor patients with metastases at diagnosis. Cancer. 1986;58:2501-2511.
19. Pritchard-Jones K, Kelsey A, Vujanic G, et al. Older age is an adverse prognostic factor in stage I, favorable histology Wilms? tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children?s Cancer Study Group, Wilm?s Tumor Working Group. J Clin Oncol. 2003; 21:3269-3275.
20. Reinhard H, Furtwängler R, Siemer S. Wilms? tumor in adults. Urologe A. 2007;46:748-753.
21. Terenziani M, Spreafico F, Collini P, et al. Adult Wilms? tumor: a mono-institutional experience and a review of the literature. Cancer. 2004;101:289-293.
22. Reinhard H, Aliani S, Ruebe C. Wilms? tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. J Clin Oncol. 2004;22:4500-4506.
23. Kalapurakal JA, Nan B, Norkool P, et al. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys. 2004;60:1379-1384.
24. Ludwig R, Weirich A, Abel U. Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Med Pediatr Oncol. 1999;3333:462-469.
25. Bisogno G, de Kraker J, Weirich A. Veno-occlusive disease of the liver in children treated for Wilms tumor. Med Pediatr Oncol. 1997;29:245-251.
26. Czauderna P, Katski K, Kowalczyk J. Venoocclusive liver disease (VOD) as a complication of Wilms? tumor management in the series of consecutive 206 patients. Eur J Pediatr Surg. 2000;10:300-303.
27. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms tumor. Int J Radiat Oncol. 2000;46:1239-1246.
28. Taylor AJ, Winter DL, Pritchard-Jones K, et al. Second primary neoplasms in survivors of Wilms? tumour-a population-based cohort study from the British Childhood Cancer Survivor Study. Int J Cancer. 2008;122:2085-2093.
29. Bassal M, Mertens AC, Taylor L. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476-483.